Obstetrical & gynecological surveyHumansCytomegalovirus InfectionsPregnancyFemaleCost-Benefit Analysis
Prenatal Screening for CMV Primary Infection: A Cost-Utility Model.
Gebrael El Hachem, Christian Renaud, Catherine McCarey, Soren Gantt, Fatima Kakkar, Marc Sab, Thomas G Poder, Isabelle Boucoiran
Published: 202510.1097/01.ogx.0001172288.00818.27
Abstract
(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or co…
Preview only. Read the full abstract at the source